$21.19
1.035.11%
最終更新: Oct 20, 5:00 PM
$21.19
1.035.11%
Benzinga
Benzinga
Benzinga
水曜日, 10 21
Benzinga
© 2026 Benzinga | All Rights Reserved
Assembly Biosciences (ASMB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.66 | $-0.71 | $-0.59 |
| Actual | $-0.20 | $-0.54 | $1.30 | $-0.72 |
| Surprise | +64.3% | +18.2% | +283.1% | -22.0% |
| Revenue | ||||
| Estimate | $7.0M | $7.4M | $8.7M | $9.7M |
| Actual | $13.4M | $8.2M | $42.5M | $10.8M |
| Surprise | +91.1% | +11.0% | +388.5% | +11.5% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.48 | $1.32 | $0.02 | $-0.83 |
| Revenue | ||||
| Consensus | $7.4M | $44.3M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.20 | $-0.56 | 64.3 % |
| Q1 | May 7, 2026 | $-0.54 | $-0.66 | 18.2 % |
| Q4 | Mar 19, 2026 | $1.30 | $-0.71 | 283.1 % |
| Q3 | Nov 10, 2025 | $-0.72 | $-0.59 | -22.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $13.37M | $7.00M | 91.1 % |
| Q1 | May 7, 2026 | $8.21M | $7.40M | 11.0 % |
| Q4 | Mar 19, 2026 | $42.47M | $8.69M | 388.5 % |
| Q3 | Nov 10, 2025 | $10.79M | $9.67M | 11.5 % |